Endothelial dysfunction induced by type 2 diabetes mellitus and fibrinolytic activity

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Problem statement: Type 2 diabetes mellitus is the world's largest systemic and metabolic disease. Endothelin (ET) was first described as a peptidergic endothelium-derived constricting factor. Endothelin-1 is one of the endothelial factors that is overexpressed in cases of endothelial dysfunction. The fibrinolytic system is present in plasma with the degradation of fibrin polymers in blood clots. It is a proteolytic mechanism that results in the formation of one main enzyme, plasmin, which cleaves fibrin. Approach: A total of 20 normal white albino rats weighing between 180-200 g were used and divided into two groups each of 10 rats, one group served as a control which fed on normal chow diet, while the second group fed on high fat diet for one month, then received streptozocin (25 mg kg-1) intraperitoneally as a single dose and continued feeding on high fat diet. Plasma was separated to determine the levels of tissue Plasminogen Activator (t-PA), Plasminogen Activator Inhibitor-1 (PAI-1), Fibrin Degradation Products (FDPs) and Euglobulin Clot Lysis Time (ECLT). Results: Data showed that diabetic rats have inhibited fibrinolytic activity as detected from the significant increase in PAI-1, significant decrease in both t-PA and TDPs with significant prolongation of the ECLT relative to the control group. Conclusion: Endothelial dysfunction is associated with a prothrombotic state.

Original languageEnglish
Pages (from-to)103-110
Number of pages8
JournalAmerican Journal of Biochemistry and Biotechnology
Volume6
Issue number2
Publication statusPublished - 2010

Fingerprint

Nutrition
Medical problems
Fibrin Clot Lysis Time
Type 2 Diabetes Mellitus
Rats
Serum Globulins
Plasminogen Activator Inhibitor 1
High Fat Diet
Tissue Plasminogen Activator
Fibrin
Fats
Fibrin Fibrinogen Degradation Products
Plasmas
Fibrinolysin
Endothelins
Metabolic Diseases
Endothelin-1
Weighing
Streptozocin
Endothelium

Keywords

  • Endothelial dysfunction
  • Endothelin-1
  • Fibrinolysis
  • Type 2 diabetes mellitus

ASJC Scopus subject areas

  • Biochemistry
  • Biotechnology

Cite this

@article{14df87c702724d3683c2430f3e992228,
title = "Endothelial dysfunction induced by type 2 diabetes mellitus and fibrinolytic activity",
abstract = "Problem statement: Type 2 diabetes mellitus is the world's largest systemic and metabolic disease. Endothelin (ET) was first described as a peptidergic endothelium-derived constricting factor. Endothelin-1 is one of the endothelial factors that is overexpressed in cases of endothelial dysfunction. The fibrinolytic system is present in plasma with the degradation of fibrin polymers in blood clots. It is a proteolytic mechanism that results in the formation of one main enzyme, plasmin, which cleaves fibrin. Approach: A total of 20 normal white albino rats weighing between 180-200 g were used and divided into two groups each of 10 rats, one group served as a control which fed on normal chow diet, while the second group fed on high fat diet for one month, then received streptozocin (25 mg kg-1) intraperitoneally as a single dose and continued feeding on high fat diet. Plasma was separated to determine the levels of tissue Plasminogen Activator (t-PA), Plasminogen Activator Inhibitor-1 (PAI-1), Fibrin Degradation Products (FDPs) and Euglobulin Clot Lysis Time (ECLT). Results: Data showed that diabetic rats have inhibited fibrinolytic activity as detected from the significant increase in PAI-1, significant decrease in both t-PA and TDPs with significant prolongation of the ECLT relative to the control group. Conclusion: Endothelial dysfunction is associated with a prothrombotic state.",
keywords = "Endothelial dysfunction, Endothelin-1, Fibrinolysis, Type 2 diabetes mellitus",
author = "Sakr, {Hussein F.}",
year = "2010",
language = "English",
volume = "6",
pages = "103--110",
journal = "American Journal of Biochemistry and Biotechnology",
issn = "1553-3468",
publisher = "Science Publications",
number = "2",

}

TY - JOUR

T1 - Endothelial dysfunction induced by type 2 diabetes mellitus and fibrinolytic activity

AU - Sakr, Hussein F.

PY - 2010

Y1 - 2010

N2 - Problem statement: Type 2 diabetes mellitus is the world's largest systemic and metabolic disease. Endothelin (ET) was first described as a peptidergic endothelium-derived constricting factor. Endothelin-1 is one of the endothelial factors that is overexpressed in cases of endothelial dysfunction. The fibrinolytic system is present in plasma with the degradation of fibrin polymers in blood clots. It is a proteolytic mechanism that results in the formation of one main enzyme, plasmin, which cleaves fibrin. Approach: A total of 20 normal white albino rats weighing between 180-200 g were used and divided into two groups each of 10 rats, one group served as a control which fed on normal chow diet, while the second group fed on high fat diet for one month, then received streptozocin (25 mg kg-1) intraperitoneally as a single dose and continued feeding on high fat diet. Plasma was separated to determine the levels of tissue Plasminogen Activator (t-PA), Plasminogen Activator Inhibitor-1 (PAI-1), Fibrin Degradation Products (FDPs) and Euglobulin Clot Lysis Time (ECLT). Results: Data showed that diabetic rats have inhibited fibrinolytic activity as detected from the significant increase in PAI-1, significant decrease in both t-PA and TDPs with significant prolongation of the ECLT relative to the control group. Conclusion: Endothelial dysfunction is associated with a prothrombotic state.

AB - Problem statement: Type 2 diabetes mellitus is the world's largest systemic and metabolic disease. Endothelin (ET) was first described as a peptidergic endothelium-derived constricting factor. Endothelin-1 is one of the endothelial factors that is overexpressed in cases of endothelial dysfunction. The fibrinolytic system is present in plasma with the degradation of fibrin polymers in blood clots. It is a proteolytic mechanism that results in the formation of one main enzyme, plasmin, which cleaves fibrin. Approach: A total of 20 normal white albino rats weighing between 180-200 g were used and divided into two groups each of 10 rats, one group served as a control which fed on normal chow diet, while the second group fed on high fat diet for one month, then received streptozocin (25 mg kg-1) intraperitoneally as a single dose and continued feeding on high fat diet. Plasma was separated to determine the levels of tissue Plasminogen Activator (t-PA), Plasminogen Activator Inhibitor-1 (PAI-1), Fibrin Degradation Products (FDPs) and Euglobulin Clot Lysis Time (ECLT). Results: Data showed that diabetic rats have inhibited fibrinolytic activity as detected from the significant increase in PAI-1, significant decrease in both t-PA and TDPs with significant prolongation of the ECLT relative to the control group. Conclusion: Endothelial dysfunction is associated with a prothrombotic state.

KW - Endothelial dysfunction

KW - Endothelin-1

KW - Fibrinolysis

KW - Type 2 diabetes mellitus

UR - http://www.scopus.com/inward/record.url?scp=77954653441&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954653441&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 103

EP - 110

JO - American Journal of Biochemistry and Biotechnology

JF - American Journal of Biochemistry and Biotechnology

SN - 1553-3468

IS - 2

ER -